HighTower Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

HighTower Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-23,900	Closed	-$9K	–	2405
2017 Q4	$9K	Buy	+23,900	New	+$59.4K	﹤0.01%	2189
2017 Q3	–	Sell	-500	Closed	-$1K	–	2404
2017 Q2	$1K	Buy	+500	New	+$2.06K	﹤0.01%	2211

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

HighTower Advisors's SGYP Position: Q1 2019 in Review

HighTower Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 49,831 shares — an estimated $5K sold.

HighTower Advisors first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $5.02M in Q4 2016. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

HighTower Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
HighTower Advisors sold 49,831 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $5K.
HighTower Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
HighTower Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $5.02M in Q4 2016.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on HighTower Advisors's 13F filing for Q1 2019, filed 15 May 2019.